Toxic complications of chemotherapy for acute lymphoblastic leukemia in children according to the ALL-MB-2008 protocol
https://doi.org/10.58708/2074-2088.2025-4(36)-59-64
Abstract
Despite advances in the treatment of acute lymphoblastic leukemia in children, the toxicity of chemotherapy remains an open question and requires further analysis and practical solutions to reduce the incidence and severity of complications. An analysis of the structure and frequency of toxic complications of polychemotherapy under the ALL-MB-2008 program was conducted in 41 children. Hematological toxicity, infectious toxicity, and hepatotoxicity were observed in 100% of patients throughout the entire treatment period. Toxic complications developed statistically significantly more frequently during the induction and consolidation therapy stages compared to maintenance therapy. Adequate supportive therapy can mitigate toxic complications and reduce mortality in pediatric patients with acute lymphoblastic leukemia.
About the Authors
A. DemidenkoBelarus
N. Klimkovich
Belarus
I. Romashevskaya
Belarus
S. Khoduleva
Belarus
E. Mitsura
Belarus
E. Borisova
Belarus
References
1. Коркина, Ю.С. Токсические эффекты программной полихимиотерапии острого лимфобластного лейкоза у детей / Ю.С. Коркина, Т.Т. Валиев // Медицинский оппонент. — 2023. — №1. — С. 29-32.
2. Ponte di Legno Toxicity Working G: Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia / B.O. Wolthers, T.L. Frandsen, А. Baruchel [et al.] // An observational pontedi legno toxicity working group study. Lancet Oncology. — 2017. — Vol. 18, №9. — Р. 1238-1248. DOI: 10.1016/S1470-2045(17)30424-2.
3. Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia / А. Yeoh, А. Collins, К. Fox [et al.] // Pediatric Hematology On cology — 2017. — Vol. 34, №1. — Р. 38-42. DOI: 10.1080/08880018.2016.127623.
4. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy / К. Schmiegelow, K. Muller, S.S. Mogensen, [et al.] // F1000Res 6. — 2017. — 444. DOI: 10.12688/f1000research.10768.1.
5. Hough, R. Crisis management in the treatment of childhood acute lymphoblastic leukemia: Putting right what can go wrong (emergency complications of disease and treatment) / R. Hough, A. Vora // Hematology Am Soc Hematol Educ Program. — 2017. — Р. 251-258. DOI: 10.1182/asheducation-2017.1.251.
6. Infection-Related Mortality in Children With Malignancy in England and Wales, 2003–2005 / J. Bate, S. Ladhani, M. Sharland // Pediatr Blood Cancer. — 2009. — Vol. 53, №3. — Р. 371–374.
7. Pediatric acute lymphoblastic leukemia / Н. Inaba, С. Mullighan // Haematologica. — 2020. — Vol. 105, №11. — P. 2524–2539. DOI: 10.3324/haematol.2020.247031.
8. Peripheral neuropathy in children and adolescents treated for cancer / K.L. Bjornard, L.S. Gilchrist // Lancet Child Adolesc Health — 2018, Vol. 2, №10. — Р. 744–754.
9. Magnetic resonance imaging of the brainin survivors of childhood acute lymphoblastic leukemia / M.A. Badr, T.H. Hassan, K.M. El-Gerby [et al.] // Oncol. Lett. — 2013. — Vol. 5, №2. — P. 621–626.
10. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia / N. Hijiya, I.M. van der Sluis // Leuk Lymphoma. — 2016. — Vol. 57, №4.— P. 748-757. DOI: 10.3109/10428194.2015.1101098.
Review
For citations:
Demidenko A., Klimkovich N., Romashevskaya I., Khoduleva S., Mitsura E., Borisova E. Toxic complications of chemotherapy for acute lymphoblastic leukemia in children according to the ALL-MB-2008 protocol. Medical and Biological Problems of Life Activity. 2025;(4):59-64. (In Russ.) https://doi.org/10.58708/2074-2088.2025-4(36)-59-64






